Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
about
Tools for outcome prediction in patients with community acquired pneumonia.Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical PneumoniaAssociations of three well-characterized polymorphisms in the IL-6 and IL-10 genes with pneumonia: a meta-analysis.Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice.IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients.Assessment of a molecular diagnostic platform for integrated isolation and quantification of mRNA in whole blood.Major advances in managing community-acquired pneumonia.Septic shock: desperately seeking treatment.Transcript profiling of the immunological interactions between Actinobacillus pleuropneumoniae serotype 7 and the host by dual RNA-seq.Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia.Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia.Differences in inflammatory marker patterns for adult community-acquired pneumonia patients induced by different pathogens.Selected Biomarkers Correlate with the Origin and Severity of Sepsis.Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia
P2860
Q30240254-6BA4065B-A855-4F15-B7C1-F037E328F7C6Q33714041-1D39049B-D5DF-4E6A-B588-1321B0896FC4Q35113884-9C1D89AC-7A93-4EAD-81ED-944E80AD85ACQ35148901-98A10DCF-E395-43EF-A5DA-E5845CDFFBBDQ35653467-8A888B49-251A-4184-AFF8-246BE5CF631DQ36167446-7DED4768-840C-4B27-AFCA-91DFA05AD02AQ37215324-02A5475C-E1F0-4EE4-832B-42D057E78AA4Q38135863-94E87F21-B57B-45A4-862C-CBD7038C4F5FQ40050850-38EB9BE3-E111-4AE2-A58A-B5D4A74DF37CQ41368108-01B93CDD-94C3-4F48-888E-38513149D688Q47160389-C320B911-0BAA-4F25-98AD-781AABFD552FQ48240599-0985CA5B-5E5F-46B8-9ED6-DB40987F0E0FQ51160587-B8DACAEA-CC7A-4D13-A4DE-32B9B137493FQ55002734-4773E08D-776A-4A6D-B63B-FF81FA8759C1Q57165953-C9FE4F37-13E6-40FB-8326-9CA9116814A5
P2860
Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@ast
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@en
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@nl
type
label
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@ast
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@en
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@nl
prefLabel
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@ast
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@en
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@nl
P2093
P2860
P921
P356
P1476
Interleukin 6, lipopolysacchar ...... man competence network CAPNETZ
@en
P2093
CAPNETZ study group
Frank Bühling
Katrin Zobel
Mathias W Pletz
Michael Prediger
Peter Martus
Santiago Ewig
P2860
P2888
P356
10.1186/1471-2466-12-6
P50
P577
2012-02-20T00:00:00Z
P5875
P6179
1023439074